NEW YORK, Jan. 20 (GenomeWeb News) - Boehringer Ingelheim has licensed a number of potential antiviral targets from Galapagos Genomics after identifying them using Galapagos' gene knock-down technology, Galapagos said yesterday.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.
Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.
HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.
Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.